EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Clear cell hidradenoma of the breast with MAML2 gene rearrangement

Li Luo, Yanping Hu

Pathology International · 2024

DOI: 10.1111/pin.13455 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology International, 2024. Verfasst von Li Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beijing Luhe Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Gene Rearrangement, Breast Neoplasms, DNA-Binding Proteins, Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell hidradenoma is a rare benign tumor of the breast, its origin and pathogenesis are controversial. We have experienced a case of breast clear cell hidradenoma with mastermind like transcriptional coactivator 2 ( MAML2 ) gene rearrangement. The patient found a painless mass with a hard texture in the left breast areola without nipple discharge. Microscopically, the tumor was cystic and solid, locally arranged in a glandular structure, covered by single cuboidal cells; it was composed of clear cells, epidermoid cells, and basaloid cells; there were no necrosis or mitotic figures. Immunohistochemical staining showed that the tumor cells positively expressed low‐molecular cytokeratin 7, low‐molecular cytokeratins (Cam5.2), high‐molecular cytokeratin 5/6, cytokeratin 14, CD117, and p63; and did not express calponin, and smooth muscle myosin heavy chain. The cuboidal cells were positive for SOX10 but negative for p63. Additionally, periodic acid‐Schiff reaction showed purple‐red granules in the tumor cytoplasm, but Alcian blue staining showed no blue mucus in the cytoplasm. The split signals of MAML2 gene were detected by fluorescence in situ hybridization. Subtle histological and immunophenotypical differences may help to distinguish breast clear cell hidradenoma from common breast tumors. Furthermore, the MAML2 gene rearrangement may be a molecular genetic characteristic of breast clear cell hidradenoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene RearrangementBreast NeoplasmsDNA-Binding ProteinsTranscription FactorsTrans-ActivatorsBiomarkers, TumorHumansFemaleIn Situ Hybridization, FluorescenceSweat Gland NeoplasmsNuclear ProteinsAdenoma, Sweat GlandMiddle AgedImmunohistochemistryAcrospiroma

Stichwörter der Autor:innen

CD117MAML2 gene rearrangementbreastcase reporthidradenoma

Substanzen

MAML2 protein, humanDNA-Binding ProteinsTranscription FactorsTrans-ActivatorsBiomarkers, TumorNuclear Proteins

Autor:innen und Institutionen

  • Department of Pathology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

Zitieren

APA

Luo, L., & Hu, Y. (2024). Clear cell hidradenoma of the breast with MAML2 gene rearrangement. Pathology International. https://doi.org/10.1111/pin.13455

Vancouver

Luo L, Hu Y. Clear cell hidradenoma of the breast with MAML2 gene rearrangement. Pathology International. 2024. doi:10.1111/pin.13455

BibTeX
@article{Luo2024,
  author = {Luo, Li and Hu, Yanping},
  title = {Clear cell hidradenoma of the breast with MAML2 gene rearrangement},
  journal = {Pathology International},
  year = {2024},
  doi = {10.1111/pin.13455}
}
Kostenlos starten →